Barry W. Hancock

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

David C. Linch, A. H. Goldstone, Annabel McMillan et al. · The Lancet · 1993 · 1.1K citations

Medicine, Hematology, Oncology +8

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

John Radford, Tim Illidge, Nicholas Counsell et al. · New England Journal of Medicine · 2015 · 750 citations · Full text

Medicine, Oncology, Radiology +16

Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment

Anthony J. Swerdlow, Julie Barber, G. Vaughan Hudson et al. · Journal of Clinical Oncology · 2000 · 478 citations

Medicine, Geriatric Medicine, Oncology +17

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

Anthony J. Swerdlow, Craig Higgins, Paul Smith et al. · JNCI Journal of the National Cancer Institute · 2007 · 448 citations

Medicine, Geriatric Medicine, Chemotherapy +12

Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study

Peter Schmid, Yutaka Nagai, Roshan Agarwal et al. · The Lancet · 2009 · 246 citations · Full text

Medicine, Gynecology, Oncology +11